Equities Research Analysts’ price target changes for Friday, November 6th:
Applied Optoelectronics (NASDAQ:AAOI) had its price target lowered by Rosenblatt Securities from $220.00 to $115.00. Rosenblatt Securities currently has a buy rating on the stock.
Applied Optoelectronics (NASDAQ:AAOI) had its price target cut by B. Riley Financial from $92.00 to $45.00. They currently have a neutral rating on the stock.
Advance Auto Parts (NYSE:AAP) had its price target boosted by Royal Bank Of Canada from $49.00 to $51.00. The firm currently has a sector perform rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target boosted by Oppenheimer from $210.00 to $230.00. They currently have an outperform rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target increased by Royal Bank Of Canada from $195.00 to $215.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target increased by Wells Fargo & Company from $185.00 to $215.00. They currently have an overweight rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target increased by Barclays from $150.00 to $195.00. They currently have an equal weight rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target boosted by Cantor Fitzgerald from $160.00 to $180.00. They currently have a neutral rating on the stock.
Airbnb (NASDAQ:ABNB) had its price target boosted by Rosenblatt Securities from $220.00 to $230.00. They currently have a buy rating on the stock.
Airbnb (NASDAQ:ABNB) had its target price boosted by Susquehanna from $200.00 to $220.00. They currently have a positive rating on the stock.
Airbnb (NASDAQ:ABNB) had its target price raised by Wedbush from $200.00 to $237.00. They currently have an outperform rating on the stock.
Acadia Healthcare (NASDAQ:ACHC) had its price target raised by Cantor Fitzgerald from $30.00 to $39.00. Cantor Fitzgerald currently has a neutral rating on the stock.
Acadia Healthcare (NASDAQ:ACHC) had its target price increased by Guggenheim from $39.00 to $41.00. The firm currently has a buy rating on the stock.
Affirm (NASDAQ:AFRM) had its target price reduced by Barclays from $105.00 to $100.00. Barclays currently has an overweight rating on the stock.
Affirm (NASDAQ:AFRM) had its price target lowered by Piper Sandler from $115.00 to $105.00. Piper Sandler currently has an overweight rating on the stock.
First Majestic Silver (NYSE:AG) (TSE:FR) had its target price cut by HC Wainwright from $25.50 to $25.00. They currently have a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price raised by HC Wainwright from $55.00 to $62.00. The firm currently has a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price reduced by Truist Financial from $37.00 to $35.00. Truist Financial currently has a buy rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its price target lowered by KeyCorp from $195.00 to $175.00. The firm currently has an overweight rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its price target lowered by Susquehanna from $140.00 to $90.00. The firm currently has a positive rating on the stock.
Albemarle (NYSE:ALB) had its target price cut by Barclays from $109.00 to $95.00. Barclays currently has an equal weight rating on the stock.
Albemarle (NYSE:ALB) had its target price trimmed by Royal Bank Of Canada from $129.00 to $119.00. They currently have an outperform rating on the stock.
Allstate (NYSE:ALL) had its target price boosted by Wells Fargo & Company from $236.00 to $252.00. The firm currently has an equal weight rating on the stock.
Alarm.com (NASDAQ:ALRM) had its price target boosted by Barclays from $60.00 to $70.00. Barclays currently has an equal weight rating on the stock.
American Homes 4 Rent (NYSE:AMH) had its target price boosted by Royal Bank Of Canada from $35.00 to $36.00. The firm currently has an outperform rating on the stock.
AMN Healthcare Services (NYSE:AMN) had its target price raised by Citizens Jmp from $40.00 to $51.00. Citizens Jmp currently has a market outperform rating on the stock.
Amphastar Pharmaceuticals (NASDAQ:AMPH) had its target price boosted by Wells Fargo & Company from $20.00 to $25.00. Wells Fargo & Company currently has an equal weight rating on the stock.
American Superconductor (NASDAQ:AMSC) had its price target cut by Oppenheimer from $71.00 to $52.00. They currently have an outperform rating on the stock.
ANI Pharmaceuticals (NASDAQ:ANIP) had its price target increased by Guggenheim from $119.00 to $121.00. Guggenheim currently has a buy rating on the stock.
Artivion (NYSE:AORT) had its price target cut by Citizens Jmp from $48.00 to $42.00. They currently have a market outperform rating on the stock.
Alpha and Omega Semiconductor (NASDAQ:AOSL) had its price target reduced by B. Riley Financial from $25.00 to $22.00. B. Riley Financial currently has a neutral rating on the stock.
Alpha and Omega Semiconductor (NASDAQ:AOSL) had its target price cut by Needham & Company LLC from $45.00 to $30.00. Needham & Company LLC currently has a buy rating on the stock.
Air Products and Chemicals (NYSE:APD) had its target price reduced by Barclays from $353.00 to $346.00. They currently have an overweight rating on the stock.
Air Products and Chemicals (NYSE:APD) had its target price raised by Royal Bank Of Canada from $346.00 to $359.00. They currently have an outperform rating on the stock.
Apollo Global Management (NYSE:APO) had its target price lowered by Argus from $160.00 to $140.00. The firm currently has a buy rating on the stock.
AppLovin (NASDAQ:APP) had its price target increased by Wells Fargo & Company from $325.00 to $347.00. The firm currently has an equal weight rating on the stock.
Ardent Health (NYSE:ARDT) had its target price increased by Royal Bank Of Canada from $13.00 to $18.00. They currently have an outperform rating on the stock.
Arrow Electronics (NYSE:ARW) had its target price lowered by Truist Financial from $250.00 to $230.00. The firm currently has a buy rating on the stock.
ASOS (LON:ASC) had its price target increased by Deutsche Bank Aktiengesellschaft from GBX 450 to GBX 490. They currently have a buy rating on the stock.
Astrana Health (NASDAQ:ASTH) had its price target increased by Needham & Company LLC from $41.00 to $45.00. The firm currently has a buy rating on the stock.
Atlanticus (NASDAQ:ATLC) had its price target cut by BTIG Research from $179.00 to $150.00. They currently have a buy rating on the stock.
aTyr Pharma (NASDAQ:ATYR) had its price target increased by Wells Fargo & Company from $1.00 to $4.00. The firm currently has an equal weight rating on the stock.
AvePoint (NASDAQ:AVPT) had its target price raised by Cantor Fitzgerald from $15.00 to $19.00. The firm currently has an overweight rating on the stock.
Avalo Therapeutics (NASDAQ:AVTX) had its target price reduced by Wedbush from $22.00 to $20.00. Wedbush currently has an outperform rating on the stock.
Axon Enterprise (NASDAQ:AXON) had its price target cut by Needham & Company LLC from $750.00 to $500.00. Needham & Company LLC currently has a buy rating on the stock.
Best Buy (NYSE:BBY) had its price target raised by Wells Fargo & Company from $85.00 to $95.00. The firm currently has an equal weight rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its price target boosted by Piper Sandler from $175.00 to $200.00. The firm currently has a neutral rating on the stock.
Becton, Dickinson and Company (NYSE:BDX) had its price target raised by Royal Bank Of Canada from $190.00 to $225.00. The firm currently has a sector perform rating on the stock.
BILL (NYSE:BILL) had its target price increased by Oppenheimer from $55.00 to $60.00. The firm currently has an outperform rating on the stock.
BILL (NYSE:BILL) had its price target raised by Keefe, Bruyette & Woods from $52.00 to $58.00. They currently have a market perform rating on the stock.
BlackLine (NASDAQ:BL) had its price target reduced by Piper Sandler from $35.00 to $30.00. The firm currently has a neutral rating on the stock.
Blend Labs (NYSE:BLND) had its target price reduced by Wells Fargo & Company from $3.00 to $2.00. They currently have an overweight rating on the stock.
Blend Labs (NYSE:BLND) had its target price cut by Citizens Jmp from $4.00 to $2.50. The firm currently has a market outperform rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its price target reduced by Royal Bank Of Canada from $22.00 to $21.00. The firm currently has an outperform rating on the stock.
Bentley Systems (NASDAQ:BSY) had its price target boosted by Royal Bank Of Canada from $48.00 to $52.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Bentley Systems (NASDAQ:BSY) had its price target boosted by Cantor Fitzgerald from $42.00 to $55.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Bentley Systems (NASDAQ:BSY) had its target price raised by Rosenblatt Securities from $50.00 to $53.00. The firm currently has a buy rating on the stock.
Cardinal Health (NYSE:CAH) had its target price increased by Royal Bank Of Canada from $276.00 to $295.00. The firm currently has an outperform rating on the stock.
CarGurus (NASDAQ:CARG) had its target price cut by Royal Bank Of Canada from $42.00 to $41.00. The firm currently has an outperform rating on the stock.
Cars.com (NYSE:CARS) had its target price boosted by B. Riley Financial from $13.00 to $15.00. B. Riley Financial currently has a neutral rating on the stock.
C4 Therapeutics (NASDAQ:CCCC) had its target price trimmed by Guggenheim from $7.00 to $6.00. Guggenheim currently has a buy rating on the stock.
Celcuity (NASDAQ:CELC) had its target price trimmed by Guggenheim from $171.00 to $169.00. The firm currently has a buy rating on the stock.
Celsius (NASDAQ:CELH) had its price target increased by Needham & Company LLC from $35.00 to $40.00. The firm currently has a buy rating on the stock.
Century Aluminum (NASDAQ:CENX) had its price target reduced by Wells Fargo & Company from $79.00 to $71.00. They currently have an overweight rating on the stock.
Certara (NASDAQ:CERT) had its target price boosted by Barclays from $9.00 to $12.00. They currently have an equal weight rating on the stock.
Carlyle Group (NASDAQ:CG) had its target price reduced by Barclays from $53.00 to $48.00. They currently have an overweight rating on the stock.
Cognex (NASDAQ:CGNX) had its target price lowered by Needham & Company LLC from $80.00 to $70.00. They currently have a buy rating on the stock.
Cognex (NASDAQ:CGNX) had its price target reduced by KeyCorp from $80.00 to $65.00. They currently have an overweight rating on the stock.
Cognex (NASDAQ:CGNX) had its price target trimmed by Truist Financial from $74.00 to $57.00. Truist Financial currently has a hold rating on the stock.
Chord Energy (NASDAQ:CHRD) had its target price boosted by Truist Financial from $195.00 to $197.00. They currently have a buy rating on the stock.
Chord Energy (NASDAQ:CHRD) had its target price trimmed by Wells Fargo & Company from $174.00 to $173.00. They currently have an overweight rating on the stock.
Cigna Group (NYSE:CI) had its target price lowered by Guggenheim from $361.00 to $347.00. The firm currently has a buy rating on the stock.
Cummins (NYSE:CMI) had its price target lowered by Wells Fargo & Company from $608.00 to $520.00. Wells Fargo & Company currently has an overweight rating on the stock.
Cummins (NYSE:CMI) had its target price lowered by Truist Financial from $779.00 to $637.00. Truist Financial currently has a buy rating on the stock.
Collegium Pharmaceutical (NASDAQ:COLL) had its target price trimmed by Piper Sandler from $43.00 to $28.00. The firm currently has a neutral rating on the stock.
Compass (NYSE:COMP) had its price target lowered by BTIG Research from $15.00 to $13.00. They currently have a buy rating on the stock.
Compass (NYSE:COMP) had its price target trimmed by Wells Fargo & Company from $10.00 to $9.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Compass (NYSE:COMP) had its price target cut by Barclays from $16.00 to $14.00. The firm currently has an overweight rating on the stock.
ConocoPhillips (NYSE:COP) had its price target cut by Wells Fargo & Company from $189.00 to $185.00. They currently have an overweight rating on the stock.
Core Scientific (NASDAQ:CORZ) had its price target cut by Needham & Company LLC from $35.00 to $28.00. The firm currently has a buy rating on the stock.
Coty (NYSE:COTY) had its price target raised by Royal Bank Of Canada from $3.00 to $3.50. The firm currently has a sector perform rating on the stock.
Croda International (LON:CRDA) had its price target boosted by Berenberg Bank from GBX 3,600 to GBX 4,400. The firm currently has a buy rating on the stock.
CRH (NYSE:CRH) had its price target boosted by Wells Fargo & Company from $100.00 to $107.00. Wells Fargo & Company currently has an overweight rating on the stock.
Corsair Gaming (NASDAQ:CRSR) had its price target trimmed by Barclays from $15.00 to $14.00. They currently have an overweight rating on the stock.
Castle Biosciences (NASDAQ:CSTL) had its price target increased by KeyCorp from $35.00 to $40.00. They currently have an overweight rating on the stock.
Carriage Services (NYSE:CSV) had its target price trimmed by B. Riley Financial from $65.00 to $56.00. B. Riley Financial currently has a buy rating on the stock.
CytomX Therapeutics (NASDAQ:CTMX) had its price target boosted by Wedbush from $11.00 to $12.00. Wedbush currently has an outperform rating on the stock.
CTO Realty Growth (NYSE:CTO) had its target price trimmed by Cantor Fitzgerald from $25.00 to $23.00. The firm currently has an overweight rating on the stock.
Centuri (NYSE:CTRI) had its target price trimmed by Wells Fargo & Company from $28.00 to $24.00. Wells Fargo & Company currently has an overweight rating on the stock.
Curtiss-Wright (NYSE:CW) had its target price trimmed by Guggenheim from $786.00 to $674.00. They currently have a buy rating on the stock.
Curtiss-Wright (NYSE:CW) had its price target trimmed by Piper Sandler from $586.00 to $544.00. They currently have a neutral rating on the stock.
CryoPort (NASDAQ:CYRX) had its target price increased by KeyCorp from $17.00 to $20.00. They currently have an overweight rating on the stock.
DoorDash (NASDAQ:DASH) had its price target cut by Rosenblatt Securities from $270.00 to $225.00. The firm currently has a buy rating on the stock.
Dropbox (NASDAQ:DBX) had its target price boosted by Royal Bank Of Canada from $42.00 to $48.00. The firm currently has an outperform rating on the stock.
Ducommun (NYSE:DCO) had its target price trimmed by Royal Bank Of Canada from $180.00 to $155.00. They currently have a sector perform rating on the stock.
Ducommun (NYSE:DCO) had its price target trimmed by B. Riley Financial from $222.00 to $203.00. They currently have a buy rating on the stock.
Diageo (LON:DGE) had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 1,734 to GBX 1,740. They currently have a hold rating on the stock.
Diodes (NASDAQ:DIOD) had its price target cut by Needham & Company LLC from $110.00 to $100.00. The firm currently has a buy rating on the stock.
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) had its target price reduced by Guggenheim from $60.00 to $59.00. Guggenheim currently has a buy rating on the stock.
DNOW (NYSE:DNOW) had its target price cut by Susquehanna from $19.00 to $18.00. The firm currently has a positive rating on the stock.
Doximity (NYSE:DOCS) had its target price increased by Royal Bank Of Canada from $28.00 to $34.00. The firm currently has an outperform rating on the stock.
Devon Energy (NYSE:DVN) had its target price trimmed by Barclays from $60.00 to $57.00. They currently have an overweight rating on the stock.
eEnergy Group (LON:EAAS) had its price target lowered by Canaccord Genuity Group to GBX 0.90. Canaccord Genuity Group currently has a buy rating on the stock.
Consolidated Edison (NYSE:ED) had its target price raised by Barclays from $106.00 to $108.00. They currently have an underweight rating on the stock.
Consolidated Edison (NYSE:ED) had its price target increased by Wells Fargo & Company from $118.00 to $134.00. They currently have an overweight rating on the stock.
Man Group (LON:EMG) had its target price lowered by Deutsche Bank Aktiengesellschaft from GBX 365 to GBX 355. The firm currently has a hold rating on the stock.
Enovis (NYSE:ENOV) had its target price boosted by Wells Fargo & Company from $33.00 to $37.00. The firm currently has an overweight rating on the stock.
EOG Resources (NYSE:EOG) had its target price boosted by Barclays from $147.00 to $155.00. They currently have an equal weight rating on the stock.
EPAM Systems (NYSE:EPAM) had its target price raised by Wells Fargo & Company from $156.00 to $176.00. The firm currently has an overweight rating on the stock.
EPAM Systems (NYSE:EPAM) had its price target boosted by Susquehanna from $146.00 to $190.00. Susquehanna currently has a positive rating on the stock.
EPAM Systems (NYSE:EPAM) had its price target raised by Wedbush from $99.00 to $160.00. Wedbush currently has a neutral rating on the stock.
EPAM Systems (NYSE:EPAM) had its target price raised by Truist Financial from $110.00 to $150.00. They currently have a hold rating on the stock.
EPR Properties (NYSE:EPR) had its price target increased by Truist Financial from $61.00 to $65.00. The firm currently has a hold rating on the stock.
Eton Pharmaceuticals (NASDAQ:ETON) had its target price raised by HC Wainwright from $70.00 to $80.00. The firm currently has a buy rating on the stock.
EverCommerce (NASDAQ:EVCM) had its target price trimmed by Royal Bank Of Canada from $10.00 to $7.00. The firm currently has a sector perform rating on the stock.
EverCommerce (NASDAQ:EVCM) had its target price reduced by Oppenheimer from $13.00 to $11.00. The firm currently has an outperform rating on the stock.
Evolent Health (NYSE:EVH) had its target price raised by Oppenheimer from $6.00 to $7.00. Oppenheimer currently has an outperform rating on the stock.
Evotec (NASDAQ:EVO) had its price target raised by HC Wainwright from $4.00 to $5.00. They currently have a buy rating on the stock.
Expedia Group (NASDAQ:EXPE) had its price target reduced by Susquehanna from $315.00 to $310.00. The firm currently has a neutral rating on the stock.
First Advantage (NYSE:FA) had its price target boosted by Needham & Company LLC from $28.00 to $30.00. The firm currently has a buy rating on the stock.
First Advantage (NYSE:FA) had its price target raised by Barclays from $30.00 to $34.00. The firm currently has an overweight rating on the stock.
Fate Therapeutics (NASDAQ:FATE) had its target price cut by Wells Fargo & Company from $3.50 to $3.00. They currently have an equal weight rating on the stock.
FactSet Research Systems (NYSE:FDS) had its target price increased by Barclays from $250.00 to $305.00. The firm currently has an underweight rating on the stock.
FIGS (NYSE:FIGS) had its price target raised by KeyCorp from $20.00 to $27.00. KeyCorp currently has an overweight rating on the stock.
Five9 (NASDAQ:FIVN) had its target price raised by KeyCorp from $32.00 to $34.00. They currently have an overweight rating on the stock.
Five9 (NASDAQ:FIVN) had its price target reduced by Barclays from $40.00 to $38.00. The firm currently has an overweight rating on the stock.
Five9 (NASDAQ:FIVN) had its price target reduced by Wells Fargo & Company from $36.00 to $28.00. They currently have an equal weight rating on the stock.
Five9 (NASDAQ:FIVN) had its price target lowered by Truist Financial from $40.00 to $35.00. The firm currently has a buy rating on the stock.
Full House Resorts (NASDAQ:FLL) had its target price trimmed by Citizens Jmp from $3.00 to $2.00. Citizens Jmp currently has a market outperform rating on the stock.
Shift4 Payments (NYSE:FOUR) had its price target cut by Wells Fargo & Company from $59.00 to $46.00. Wells Fargo & Company currently has an overweight rating on the stock.
Shift4 Payments (NYSE:FOUR) had its target price trimmed by Susquehanna from $63.00 to $56.00. The firm currently has a positive rating on the stock.
JFrog (NASDAQ:FROG) had its price target increased by KeyCorp from $114.00 to $118.00. KeyCorp currently has an overweight rating on the stock.
JFrog (NASDAQ:FROG) had its price target increased by Piper Sandler from $90.00 to $95.00. The firm currently has a neutral rating on the stock.
JFrog (NASDAQ:FROG) had its target price boosted by Royal Bank Of Canada from $118.00 to $121.00. They currently have an outperform rating on the stock.
JFrog (NASDAQ:FROG) had its price target boosted by Truist Financial from $115.00 to $120.00. The firm currently has a buy rating on the stock.
Frontdoor (NASDAQ:FTDR) had its price target boosted by Truist Financial from $105.00 to $115.00. The firm currently has a buy rating on the stock.
Six Flags Entertainment (NYSE:FUN) had its target price cut by Barclays from $22.00 to $13.00. The firm currently has an overweight rating on the stock.
FrontView REIT (NYSE:FVR) had its price target lowered by JonesTrading from $21.00 to $20.00. JonesTrading currently has a buy rating on the stock.
Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) had its price target increased by Wells Fargo & Company from $96.00 to $113.00. Wells Fargo & Company currently has an equal weight rating on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its price target increased by Guggenheim from $20.00 to $21.00. The firm currently has a buy rating on the stock.
Genpact (NYSE:G) had its target price increased by Susquehanna from $40.00 to $42.00. Susquehanna currently has a neutral rating on the stock.
Genpact (NYSE:G) had its price target increased by Needham & Company LLC from $45.00 to $55.00. They currently have a buy rating on the stock.
Genius Sports (NYSE:GENI) had its price target reduced by Oppenheimer from $12.00 to $10.00. The firm currently has an outperform rating on the stock.
Genius Sports (NYSE:GENI) had its price target increased by Guggenheim from $12.00 to $13.00. The firm currently has a buy rating on the stock.
Gildan Activewear (NYSE:GIL) (TSE:GIL) had its target price reduced by Royal Bank Of Canada from $70.00 to $50.00. They currently have an outperform rating on the stock.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its price target trimmed by Wells Fargo & Company from $27.00 to $25.00. They currently have an overweight rating on the stock.
Globus Medical (NYSE:GMED) had its price target lowered by Needham & Company LLC from $117.00 to $100.00. Needham & Company LLC currently has a buy rating on the stock.
Globus Medical (NYSE:GMED) had its target price increased by Wells Fargo & Company from $99.00 to $100.00. They currently have an overweight rating on the stock.
Global Net Lease (NYSE:GNL) had its price target cut by Cantor Fitzgerald from $11.00 to $9.00. The firm currently has an overweight rating on the stock.
Global Payments (NYSE:GPN) had its target price boosted by KeyCorp from $105.00 to $112.00. The firm currently has an overweight rating on the stock.
Global Payments (NYSE:GPN) had its target price increased by Wells Fargo & Company from $103.00 to $116.00. Wells Fargo & Company currently has an overweight rating on the stock.
Gulfport Energy (NYSE:GPOR) had its price target boosted by Truist Financial from $186.00 to $192.00. Truist Financial currently has a hold rating on the stock.
GXO Logistics (NYSE:GXO) had its price target raised by Susquehanna from $60.00 to $66.00. Susquehanna currently has a positive rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its target price increased by Citizens Jmp from $93.00 to $149.00. Citizens Jmp currently has a market outperform rating on the stock.
Halozyme Therapeutics (NASDAQ:HALO) had its target price increased by Wells Fargo & Company from $95.00 to $110.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Hikma Pharmaceuticals (LON:HIK) had its target price lowered by Deutsche Bank Aktiengesellschaft from GBX 2,050 to GBX 2,000. They currently have a buy rating on the stock.
Helios Technologies (NYSE:HLIO) had its target price reduced by KeyCorp from $95.00 to $85.00. The firm currently has an overweight rating on the stock.
Helios Towers (LON:HTWS) had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 285 to GBX 290. They currently have a buy rating on the stock.
Installed Building Products (NYSE:IBP) had its target price lowered by Royal Bank Of Canada from $208.00 to $194.00. They currently have a sector perform rating on the stock.
Installed Building Products (NYSE:IBP) had its target price boosted by Truist Financial from $160.00 to $180.00. They currently have a hold rating on the stock.
ICU Medical (NASDAQ:ICUI) had its price target raised by Piper Sandler from $195.00 to $200.00. The firm currently has an overweight rating on the stock.
ICU Medical (NASDAQ:ICUI) had its target price boosted by KeyCorp from $187.00 to $189.00. They currently have an overweight rating on the stock.
International Flavors & Fragrances (NYSE:IFF) had its target price cut by Barclays from $105.00 to $103.00. They currently have an overweight rating on the stock.
IMAX (NYSE:IMAX) had its target price trimmed by Wells Fargo & Company from $55.00 to $52.00. The firm currently has an equal weight rating on the stock.
indie Semiconductor (NASDAQ:INDI) had its target price reduced by B. Riley Financial from $5.00 to $4.00. The firm currently has a buy rating on the stock.
Inspired Entertainment (NASDAQ:INSE) had its target price cut by B. Riley Financial from $8.75 to $6.25. B. Riley Financial currently has a buy rating on the stock.
Inspired Entertainment (NASDAQ:INSE) had its price target reduced by Citizens Jmp from $9.00 to $7.00. The firm currently has a market outperform rating on the stock.
IonQ (NYSE:IONQ) had its price target trimmed by Cantor Fitzgerald from $70.00 to $60.00. The firm currently has an overweight rating on the stock.
IonQ (NYSE:IONQ) had its price target reduced by Needham & Company LLC from $65.00 to $48.00. They currently have a buy rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price boosted by Citizens Jmp from $8.00 to $12.00. The firm currently has a market outperform rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price raised by Barclays from $18.00 to $19.00. They currently have an overweight rating on the stock.
IREN (NASDAQ:IREN) had its price target lowered by Cantor Fitzgerald from $99.00 to $47.00. The firm currently has an overweight rating on the stock.
Disc Medicine (NASDAQ:IRON) had its target price increased by HC Wainwright from $120.00 to $127.00. The firm currently has a buy rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its price target reduced by BTIG Research from $185.00 to $170.00. They currently have a buy rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its price target trimmed by Needham & Company LLC from $194.00 to $165.00. Needham & Company LLC currently has a buy rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its price target lowered by Piper Sandler from $160.00 to $150.00. Piper Sandler currently has an overweight rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its target price trimmed by Wells Fargo & Company from $150.00 to $135.00. They currently have an overweight rating on the stock.
Janux Therapeutics (NASDAQ:JANX) had its price target increased by Barclays from $14.00 to $15.00. They currently have an underweight rating on the stock.
Janux Therapeutics (NASDAQ:JANX) had its price target raised by Wedbush from $36.00 to $40.00. Wedbush currently has an outperform rating on the stock.
Janux Therapeutics (NASDAQ:JANX) had its price target boosted by Truist Financial from $26.00 to $27.00. They currently have a buy rating on the stock.
James Hardie Industries (NYSE:JHX) had its target price cut by Truist Financial from $40.00 to $37.00. They currently have a buy rating on the stock.
Kodiak AI (NASDAQ:KDK) had its price target reduced by Needham & Company LLC to $4.00. They currently have a buy rating on the stock.
Kimberly-Clark (NASDAQ:KMB) had its target price raised by Piper Sandler from $118.00 to $137.00. They currently have an overweight rating on the stock.
Kimberly-Clark (NASDAQ:KMB) had its price target raised by Wells Fargo & Company from $100.00 to $110.00. They currently have an equal weight rating on the stock.
Karman (NYSE:KRMN) had its price target reduced by Needham & Company LLC from $80.00 to $50.00. The firm currently has a buy rating on the stock.
Kratos Defense & Security Solutions (NASDAQ:KTOS) had its price target lowered by BTIG Research from $104.00 to $65.00. They currently have a buy rating on the stock.
Lamar Advertising (NASDAQ:LAMR) had its target price boosted by Wells Fargo & Company from $156.00 to $158.00. The firm currently has an equal weight rating on the stock.
Centrus Energy (NYSE:LEU) had its price target reduced by Barclays from $150.00 to $149.00. They currently have an equal weight rating on the stock.
LifeStance Health Group (NASDAQ:LFST) had its price target increased by KeyCorp from $15.00 to $17.00. The firm currently has an overweight rating on the stock.
Lemonade (NYSE:LMND) had its price target cut by Citizens Jmp from $80.00 to $75.00. Citizens Jmp currently has a market outperform rating on the stock.
Lemonade (NYSE:LMND) had its target price cut by Piper Sandler from $51.00 to $47.00. Piper Sandler currently has a neutral rating on the stock.
Lemonade (NYSE:LMND) had its target price cut by Truist Financial from $70.00 to $60.00. They currently have a buy rating on the stock.
Lyft (NASDAQ:LYFT) had its target price increased by Truist Financial from $16.00 to $18.00. The firm currently has a hold rating on the stock.
Lyft (NASDAQ:LYFT) had its target price trimmed by Rosenblatt Securities from $19.00 to $18.00. Rosenblatt Securities currently has a neutral rating on the stock.
Live Nation Entertainment (NYSE:LYV) had its target price reduced by Wells Fargo & Company from $222.00 to $221.00. The firm currently has an overweight rating on the stock.
McDonald’s (NYSE:MCD) had its target price raised by Argus from $310.00 to $320.00. Argus currently has a buy rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target trimmed by Wells Fargo & Company from $80.00 to $70.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target reduced by KeyCorp from $135.00 to $120.00. The firm currently has an overweight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target lowered by B. Riley Financial from $98.00 to $85.00. They currently have a buy rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target cut by Needham & Company LLC from $120.00 to $85.00. The firm currently has a buy rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price lowered by Rosenblatt Securities from $120.00 to $115.00. Rosenblatt Securities currently has a buy rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its target price lowered by Cantor Fitzgerald from $125.00 to $100.00. The firm currently has an overweight rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target reduced by Susquehanna from $120.00 to $100.00. Susquehanna currently has a positive rating on the stock.
Microchip Technology (NASDAQ:MCHP) had its price target reduced by Truist Financial from $90.00 to $62.00. The firm currently has a hold rating on the stock.
Magnolia Oil & Gas (NYSE:MGY) had its price target trimmed by Wells Fargo & Company from $30.00 to $29.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Marks and Spencer Group (LON:MKS) had its target price raised by Deutsche Bank Aktiengesellschaft from GBX 435 to GBX 470. The firm currently has a buy rating on the stock.
MKS (NASDAQ:MKSI) had its price target cut by Wells Fargo & Company from $285.00 to $195.00. The firm currently has an equal weight rating on the stock.
MannKind (NASDAQ:MNKD) had its price target raised by Cantor Fitzgerald from $8.00 to $10.00. The firm currently has an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target boosted by Wells Fargo & Company from $50.00 to $52.00. Wells Fargo & Company currently has an overweight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its price target raised by Piper Sandler from $50.50 to $53.00. They currently have an overweight rating on the stock.
Marex Group plc Ordinary Shares (NASDAQ:MRX) had its target price boosted by Barclays from $92.00 to $95.00. They currently have an overweight rating on the stock.
MGIC Investment (NYSE:MTG) had its price target raised by Barclays from $29.00 to $30.00. They currently have an equal weight rating on the stock.
MACOM Technology Solutions (NASDAQ:MTSI) had its price target reduced by Truist Financial from $375.00 to $310.00. They currently have a buy rating on the stock.
Manitowoc (NYSE:MTW) had its target price raised by Barclays from $16.00 to $20.00. They currently have an underweight rating on the stock.
Mueller Water Products (NYSE:MWA) had its target price cut by Barclays from $25.00 to $24.00. The firm currently has an underweight rating on the stock.
Cloudflare (NYSE:NET) had its target price lowered by Cantor Fitzgerald from $340.00 to $310.00. They currently have a neutral rating on the stock.
Cloudflare (NYSE:NET) had its price target cut by Needham & Company LLC from $380.00 to $365.00. The firm currently has a buy rating on the stock.
Cloudflare (NYSE:NET) had its price target cut by Scotiabank from $390.00 to $360.00. They currently have a sector outperform rating on the stock.
Next 15 Group (LON:NFG) had its price target cut by Berenberg Bank from GBX 510 to GBX 475. The firm currently has a buy rating on the stock.
NMI (NASDAQ:NMIH) had its price target trimmed by Barclays from $43.00 to $42.00. Barclays currently has an equal weight rating on the stock.
NerdWallet (NASDAQ:NRDS) had its target price trimmed by Truist Financial from $15.00 to $12.00. Truist Financial currently has a buy rating on the stock.
Nova (NASDAQ:NVMI) had its price target trimmed by Barclays from $600.00 to $500.00. The firm currently has an overweight rating on the stock.
Northwest Natural Gas (NYSE:NWN) had its target price increased by Wells Fargo & Company from $49.00 to $50.00. The firm currently has an equal weight rating on the stock.
Nexstar Media Group (NASDAQ:NXST) had its price target raised by Wells Fargo & Company from $249.00 to $250.00. The firm currently has an overweight rating on the stock.
Old Dominion Freight Line (NASDAQ:ODFL) had its price target reduced by Susquehanna from $202.00 to $200.00. They currently have a neutral rating on the stock.
Omada Health (NASDAQ:OMDA) had its target price lowered by Wells Fargo & Company from $22.00 to $19.00. They currently have an equal weight rating on the stock.
Omada Health (NASDAQ:OMDA) had its price target cut by Barclays from $24.00 to $22.00. Barclays currently has an overweight rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its target price increased by Royal Bank Of Canada from $459.00 to $465.00. They currently have an outperform rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its price target raised by Wells Fargo & Company from $400.00 to $435.00. Wells Fargo & Company currently has an overweight rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its target price increased by Citizens Jmp from $405.00 to $463.00. They currently have a market outperform rating on the stock.
BeOne Medicines (NASDAQ:ONC) had its price target boosted by Barclays from $415.00 to $446.00. Barclays currently has an overweight rating on the stock.
Montrose Environmental Group (NYSE:ONT) had its target price increased by Barclays from $15.00 to $19.00. They currently have an equal weight rating on the stock.
Ormat Technologies (NYSE:ORA) had its price target trimmed by Barclays from $122.00 to $113.00. They currently have an overweight rating on the stock.
Ormat Technologies (NYSE:ORA) had its target price lowered by Oppenheimer from $145.00 to $130.00. The firm currently has an outperform rating on the stock.
Oscar Health (NYSE:OSCR) had its price target cut by Piper Sandler from $48.00 to $45.00. They currently have an overweight rating on the stock.
Open Text (NASDAQ:OTEX) (TSE:OTC) had its price target increased by Barclays from $27.00 to $29.00. They currently have an equal weight rating on the stock.
Blue Owl Technology Finance (NYSE:OTF) had its price target lowered by Wells Fargo & Company from $12.00 to $11.00. The firm currently has an overweight rating on the stock.
PAR Technology (NYSE:PAR) had its target price raised by Needham & Company LLC from $25.00 to $30.00. Needham & Company LLC currently has a buy rating on the stock.
Paylocity (NASDAQ:PCTY) had its price target increased by BTIG Research from $200.00 to $210.00. The firm currently has a buy rating on the stock.
Paylocity (NASDAQ:PCTY) had its target price increased by Citizens Jmp from $180.00 to $200.00. Citizens Jmp currently has a market outperform rating on the stock.
Paylocity (NASDAQ:PCTY) had its target price boosted by Barclays from $162.00 to $176.00. The firm currently has an equal weight rating on the stock.
PDF Solutions (NASDAQ:PDFS) had its target price cut by Wells Fargo & Company from $50.00 to $39.00. Wells Fargo & Company currently has an equal weight rating on the stock.
PENN Entertainment (NASDAQ:PENN) had its price target raised by Wells Fargo & Company from $22.00 to $23.00. They currently have an equal weight rating on the stock.
Palomar (NASDAQ:PLMR) had its price target raised by Piper Sandler from $165.00 to $174.00. They currently have an overweight rating on the stock.
Planet Fitness (NYSE:PLNT) had its target price boosted by Wells Fargo & Company from $65.00 to $75.00. They currently have an overweight rating on the stock.
Planet Fitness (NYSE:PLNT) had its target price increased by KeyCorp from $65.00 to $68.00. KeyCorp currently has an overweight rating on the stock.
Pulse Biosciences (NASDAQ:PLSE) had its target price increased by Needham & Company LLC from $58.00 to $64.00. Needham & Company LLC currently has a buy rating on the stock.
Insulet (NASDAQ:PODD) had its target price raised by Barclays from $150.00 to $165.00. They currently have an equal weight rating on the stock.
Permian Resources (NYSE:PR) had its price target reduced by Wells Fargo & Company from $28.00 to $27.00. They currently have an overweight rating on the stock.
PROCEPT BioRobotics (NASDAQ:PRCT) had its target price increased by Truist Financial from $21.00 to $24.00. They currently have a hold rating on the stock.
Primoris Services (NYSE:PRIM) had its price target lowered by Wells Fargo & Company from $85.00 to $64.00. They currently have an equal weight rating on the stock.
Privia Health Group (NASDAQ:PRVA) had its price target increased by Piper Sandler from $36.00 to $38.00. The firm currently has an overweight rating on the stock.
Prospect Capital (NASDAQ:PSEC) had its price target lowered by Wells Fargo & Company from $2.00 to $1.50. They currently have an underweight rating on the stock.
Portillo’s (NASDAQ:PTLO) had its target price increased by DA Davidson from $5.00 to $7.00. They currently have a neutral rating on the stock.
Portillo’s (NASDAQ:PTLO) had its price target increased by Stephens from $5.00 to $7.00. They currently have an equal weight rating on the stock.
Hyperliquid Strategies (NASDAQ:PURR) had its price target raised by Cantor Fitzgerald from $34.30 to $35.00. The firm currently has an overweight rating on the stock.
Palvella Therapeutics (NASDAQ:PVLA) had its price target increased by Oppenheimer from $210.00 to $232.00. Oppenheimer currently has an outperform rating on the stock.
Pyxis Oncology (NASDAQ:PYXS) had its target price reduced by Wedbush from $8.00 to $7.00. The firm currently has an outperform rating on the stock.
Qnity Electronics (NYSE:Q) had its target price raised by Barclays from $211.00 to $216.00. The firm currently has an overweight rating on the stock.
Quantinuum (NASDAQ:QNT) had its target price reduced by Cantor Fitzgerald from $90.00 to $55.00. They currently have an overweight rating on the stock.
Quantinuum (NASDAQ:QNT) had its price target reduced by Needham & Company LLC from $100.00 to $60.00. The firm currently has a buy rating on the stock.
Avita Medical (NASDAQ:RCEL) had its target price boosted by BTIG Research from $15.00 to $21.00. The firm currently has a buy rating on the stock.
Radian Group (NYSE:RDN) had its price target raised by Barclays from $36.00 to $37.00. Barclays currently has an equal weight rating on the stock.
Redwire (NYSE:RDW) had its target price cut by B. Riley Financial from $15.00 to $14.00. They currently have a buy rating on the stock.
Redwire (NYSE:RDW) had its price target cut by Piper Sandler from $11.00 to $8.00. The firm currently has a neutral rating on the stock.
Reformation (NYSE:REF) had its price target raised by BTIG Research from $20.00 to $21.00. They currently have a buy rating on the stock.
Rigel Pharmaceuticals (NASDAQ:RIGL) had its price target boosted by Cantor Fitzgerald from $43.00 to $47.00. The firm currently has a neutral rating on the stock.
Ralph Lauren (NYSE:RL) had its price target boosted by Barclays from $463.00 to $473.00. They currently have an overweight rating on the stock.
Construction Partners (NASDAQ:ROAD) had its price target reduced by Truist Financial from $130.00 to $90.00. The firm currently has a hold rating on the stock.
Rapid7 (NASDAQ:RPD) had its target price raised by Susquehanna from $15.00 to $16.00. The firm currently has a neutral rating on the stock.
RS Group (LON:RS1) had its target price boosted by Deutsche Bank Aktiengesellschaft from GBX 850 to GBX 885. They currently have a buy rating on the stock.
Revolution Medicines (NASDAQ:RVMD) had its price target raised by HC Wainwright from $280.00 to $350.00. HC Wainwright currently has a buy rating on the stock.
Seaport Entertainment Gr (NYSE:SEG) had its price target cut by JonesTrading from $36.00 to $30.00. They currently have a buy rating on the stock.
Solaris Energy Infrastructure (NYSE:SEI) had its price target raised by Barclays from $116.00 to $140.00. They currently have an overweight rating on the stock.
Solaris Energy Infrastructure (NYSE:SEI) had its price target reduced by Wells Fargo & Company from $72.00 to $65.00. Wells Fargo & Company currently has an overweight rating on the stock.
Septerna (NASDAQ:SEPN) had its price target increased by Guggenheim from $51.00 to $65.00. They currently have a buy rating on the stock.
Sweetgreen (NYSE:SG) had its price target boosted by KeyCorp from $12.00 to $13.00. KeyCorp currently has an overweight rating on the stock.
Sweetgreen (NYSE:SG) had its target price boosted by TD Cowen from $9.00 to $11.00. They currently have a hold rating on the stock.
Sweetgreen (NYSE:SG) had its target price increased by Wells Fargo & Company from $11.00 to $14.00. Wells Fargo & Company currently has an overweight rating on the stock.
Sweetgreen (NYSE:SG) had its price target increased by Oppenheimer from $8.50 to $14.00. Oppenheimer currently has an outperform rating on the stock.
Skyward Specialty Insurance Group (NASDAQ:SKWD) had its price target boosted by Barclays from $68.00 to $71.00. Barclays currently has an overweight rating on the stock.
SLR Investment (NASDAQ:SLRC) had its target price reduced by B. Riley Financial from $14.00 to $13.00. B. Riley Financial currently has a buy rating on the stock.
NuScale Power (NYSE:SMR) had its target price reduced by Cantor Fitzgerald from $20.00 to $15.00. The firm currently has an overweight rating on the stock.
Sonida Senior Living (NYSE:SNDA) had its price target reduced by Citizens Jmp from $50.00 to $45.00. Citizens Jmp currently has a market outperform rating on the stock.
Schneider National (NYSE:SNDR) had its price target cut by Susquehanna from $36.00 to $34.00. They currently have a neutral rating on the stock.
Solventum (NYSE:SOLV) had its price target boosted by Wells Fargo & Company from $89.00 to $95.00. The firm currently has an equal weight rating on the stock.
SoundHound AI (NASDAQ:SOUN) had its target price cut by Cantor Fitzgerald from $15.00 to $10.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Sphere Entertainment (NYSE:SPHR) had its price target trimmed by Guggenheim from $180.00 to $175.00. The firm currently has a buy rating on the stock.
STERIS (NYSE:STE) had its target price raised by KeyCorp from $269.00 to $284.00. The firm currently has an overweight rating on the stock.
StepStone Group (NASDAQ:STEP) had its target price raised by Barclays from $62.00 to $65.00. Barclays currently has an overweight rating on the stock.
Neuronetics (NASDAQ:STIM) had its target price boosted by B. Riley Financial from $5.00 to $6.00. They currently have a buy rating on the stock.
Oncology Institute (NASDAQ:STLN) had its target price increased by BTIG Research from $9.00 to $10.00. The firm currently has a buy rating on the stock.
Molson Coors Beverage (NYSE:TAP) had its target price cut by Piper Sandler from $44.00 to $43.00. The firm currently has a neutral rating on the stock.
USA Today (NYSE:TDAY) had its price target increased by Rosenblatt Securities from $10.00 to $11.00. Rosenblatt Securities currently has a buy rating on the stock.
Teradata (NYSE:TDC) had its price target increased by Barclays from $27.00 to $28.00. They currently have an underweight rating on the stock.
Atlassian (NASDAQ:TEAM) had its target price cut by Wells Fargo & Company from $270.00 to $200.00. Wells Fargo & Company currently has an overweight rating on the stock.
Atlassian (NASDAQ:TEAM) had its target price boosted by Piper Sandler from $175.00 to $190.00. Piper Sandler currently has an overweight rating on the stock.
Atlassian (NASDAQ:TEAM) had its price target cut by BTIG Research from $260.00 to $240.00. BTIG Research currently has a buy rating on the stock.
Atlassian (NASDAQ:TEAM) had its price target lowered by Oppenheimer from $275.00 to $240.00. They currently have an outperform rating on the stock.
Teleflex (NYSE:TFX) had its target price increased by Wells Fargo & Company from $138.00 to $167.00. The firm currently has an equal weight rating on the stock.
Tandem Diabetes Care (NASDAQ:TNDM) had its price target trimmed by Wells Fargo & Company from $27.00 to $25.00. They currently have an overweight rating on the stock.
Tandem Diabetes Care (NASDAQ:TNDM) had its price target increased by Barclays from $18.00 to $20.00. Barclays currently has an equal weight rating on the stock.
Tapestry (NYSE:TPR) had its target price boosted by Barclays from $185.00 to $195.00. Barclays currently has an overweight rating on the stock.
Tapestry (NYSE:TPR) had its target price raised by Wells Fargo & Company from $150.00 to $155.00. Wells Fargo & Company currently has an overweight rating on the stock.
TripAdvisor (NASDAQ:TRIP) had its price target trimmed by Cantor Fitzgerald from $8.00 to $6.00. The firm currently has an underweight rating on the stock.
TripAdvisor (NASDAQ:TRIP) had its price target reduced by Barclays from $9.00 to $8.00. The firm currently has an underweight rating on the stock.
TripAdvisor (NASDAQ:TRIP) had its target price cut by B. Riley Financial from $12.50 to $8.50. The firm currently has a neutral rating on the stock.
Tenaris (NYSE:TS) had its price target raised by Barclays from $80.00 to $88.00. They currently have an overweight rating on the stock.
TSS (NASDAQ:TSSI) had its target price reduced by Needham & Company LLC from $13.00 to $9.00. The firm currently has a buy rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its price target lowered by Wells Fargo & Company from $230.00 to $220.00. They currently have an overweight rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its price target raised by Bank of America from $225.00 to $227.00. The firm currently has a buy rating on the stock.
Texas Roadhouse (NASDAQ:TXRH) had its price target raised by TD Cowen from $195.00 to $213.00. TD Cowen currently has a buy rating on the stock.
Unity Software (NYSE:U) had its price target raised by Needham & Company LLC from $54.00 to $70.00. Needham & Company LLC currently has a buy rating on the stock.
Unity Software (NYSE:U) had its target price increased by Citizens Jmp from $45.00 to $70.00. The firm currently has a market outperform rating on the stock.
Unity Software (NYSE:U) had its target price increased by Wells Fargo & Company from $53.00 to $64.00. They currently have an overweight rating on the stock.
Unilever (LON:ULVR) had its target price boosted by Deutsche Bank Aktiengesellschaft from GBX 5,150 to GBX 5,300. The firm currently has a hold rating on the stock.
Unusual Machines (NYSEAMERICAN:UMAC) had its target price lowered by Needham & Company LLC from $40.00 to $22.00. Needham & Company LLC currently has a buy rating on the stock.
Vericel (NASDAQ:VCEL) had its price target boosted by HC Wainwright from $72.00 to $75.00. They currently have a buy rating on the stock.
Victory Capital (NASDAQ:VCTR) had its target price raised by Barclays from $121.00 to $126.00. Barclays currently has an equal weight rating on the stock.
Veeva Systems (NYSE:VEEV) had its target price raised by Needham & Company LLC from $310.00 to $360.00. They currently have a buy rating on the stock.
Vera Therapeutics (NASDAQ:VERA) had its price target lowered by HC Wainwright from $90.00 to $75.00. The firm currently has a buy rating on the stock.
Vontier (NYSE:VNT) had its target price boosted by KeyCorp from $40.00 to $43.00. They currently have an overweight rating on the stock.
Verisk Analytics (NASDAQ:VRSK) had its price target boosted by Barclays from $225.00 to $250.00. The firm currently has an overweight rating on the stock.
Verisk Analytics (NASDAQ:VRSK) had its price target increased by Wells Fargo & Company from $260.00 to $265.00. The firm currently has an overweight rating on the stock.
Verastem (NASDAQ:VSTM) had its price target raised by HC Wainwright from $18.00 to $20.00. They currently have a buy rating on the stock.
WBI (NYSE:WBI) had its target price cut by Barclays from $34.00 to $33.00. They currently have an overweight rating on the stock.
Wendy’s (NASDAQ:WEN) had its target price raised by Stephens from $7.00 to $8.00. They currently have an equal weight rating on the stock.
Advanced Drainage Systems (NYSE:WMS) had its target price cut by Barclays from $191.00 to $183.00. Barclays currently has an overweight rating on the stock.
Advanced Drainage Systems (NYSE:WMS) had its price target cut by Royal Bank Of Canada from $170.00 to $163.00. They currently have an outperform rating on the stock.
Warby Parker (NYSE:WRBY) had its price target boosted by Citizens Jmp from $29.00 to $40.00. They currently have a market outperform rating on the stock.
WillScot (NASDAQ:WSC) had its price target lowered by Oppenheimer from $29.00 to $26.00. Oppenheimer currently has an outperform rating on the stock.
Watts Water Technologies (NYSE:WTS) had its price target lowered by Barclays from $425.00 to $424.00. Barclays currently has an overweight rating on the stock.
Wynn Resorts (NASDAQ:WYNN) had its target price lowered by Barclays from $128.00 to $120.00. Barclays currently has an overweight rating on the stock.
Wynn Resorts (NASDAQ:WYNN) had its price target trimmed by Wells Fargo & Company from $125.00 to $122.00. Wells Fargo & Company currently has an overweight rating on the stock.
Xeris Biopharma (NASDAQ:XERS) had its target price raised by HC Wainwright from $10.00 to $18.00. HC Wainwright currently has a buy rating on the stock.
Zoetis (NYSE:ZTS) had its price target boosted by Jefferies Financial Group from $83.00 to $85.00.
Receive News & Ratings for Applied Optoelectronics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Optoelectronics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
